Effects of cerebrovascular disease and amyloid beta burden on cognition in subjects with subcortical vascular cognitive impairment

Cerebrovascular disease (CVD) and amyloid burden are the most frequent pathologies in subjects with cognitive impairment. However, the relationship between CVD, amyloid burden, and cognition are largely unknown. We aimed to evaluate whether CVD (lacunes, white matter hyperintensities, and microbleed...

Full description

Saved in:
Bibliographic Details
Published inNeurobiology of aging Vol. 35; no. 1; pp. 254 - 260
Main Authors Park, Jae-Hyun, Seo, Sang Won, Kim, Changsoo, Kim, Sook Hui, Kim, Geon Ha, Kim, Sung Tae, Jeon, Seun, Lee, Jong Min, Oh, Seung Jun, Kim, Jae Seung, Choe, Yearn Seong, Lee, Kyung-Han, Shin, Ji Soo, Kim, Chi Hun, Noh, Young, Cho, Hanna, Yoon, Cindy W., Kim, Hee Jin, Ye, Byoung Seok, Ewers, Michael, Weiner, Michael W., Lee, Jae-Hong, Werring, David J., Na, Duk L.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.01.2014
Subjects
Online AccessGet full text
ISSN0197-4580
1558-1497
1558-1497
DOI10.1016/j.neurobiolaging.2013.06.026

Cover

Abstract Cerebrovascular disease (CVD) and amyloid burden are the most frequent pathologies in subjects with cognitive impairment. However, the relationship between CVD, amyloid burden, and cognition are largely unknown. We aimed to evaluate whether CVD (lacunes, white matter hyperintensities, and microbleeds) and amyloid burden (Pittsburgh compound B [PiB] retention ratio) contribute to cognitive impairment independently or interactively. We recruited 136 patients with subcortical vascular cognitive impairment who underwent magnetic resonance imaging, PiB–positron emission tomography, and neuropsychological testing. The number of lacunes was associated with memory, frontal dysfunctions, and disease severity. The volume of white matter hyperintensities and the PiB retention ratio were associated only with memory dysfunction. There was no direct correlation between CVD markers and PiB retention ratio except that the number of lacunes was negatively correlated with the PiB retention ratio. In addition, there were no interactive effects of CVD and PiB retention ratio on cognition. Our findings suggest that CVD and amyloid burden contribute independently and not interactively to specific patterns of cognitive dysfunction in patients with subcortical vascular cognitive impairment.
AbstractList Cerebrovascular disease (CVD) and amyloid burden are the most frequent pathologies in subjects with cognitive impairment. However, the relationship between CVD, amyloid burden, and cognition are largely unknown. We aimed to evaluate whether CVD (lacunes, white matter hyperintensities, and microbleeds) and amyloid burden (Pittsburgh compound B [PiB] retention ratio) contribute to cognitive impairment independently or interactively. We recruited 136 patients with subcortical vascular cognitive impairment who underwent magnetic resonance imaging, PiB–positron emission tomography, and neuropsychological testing. The number of lacunes was associated with memory, frontal dysfunctions, and disease severity. The volume of white matter hyperintensities and the PiB retention ratio were associated only with memory dysfunction. There was no direct correlation between CVD markers and PiB retention ratio except that the number of lacunes was negatively correlated with the PiB retention ratio. In addition, there were no interactive effects of CVD and PiB retention ratio on cognition. Our findings suggest that CVD and amyloid burden contribute independently and not interactively to specific patterns of cognitive dysfunction in patients with subcortical vascular cognitive impairment.
Cerebrovascular disease (CVD) and amyloid burden are the most frequent pathologies in subjects with cognitive impairment. However, the relationship between CVD, amyloid burden, and cognition are largely unknown. We aimed to evaluate whether CVD (lacunes, white matter hyperintensities, and microbleeds) and amyloid burden (Pittsburgh compound B [PiB] retention ratio) contribute to cognitive impairment independently or interactively. We recruited 136 patients with subcortical vascular cognitive impairment who underwent magnetic resonance imaging, PiB-positron emission tomography, and neuropsychological testing. The number of lacunes was associated with memory, frontal dysfunctions, and disease severity. The volume of white matter hyperintensities and the PiB retention ratio were associated only with memory dysfunction. There was no direct correlation between CVD markers and PiB retention ratio except that the number of lacunes was negatively correlated with the PiB retention ratio. In addition, there were no interactive effects of CVD and PiB retention ratio on cognition. Our findings suggest that CVD and amyloid burden contribute independently and not interactively to specific patterns of cognitive dysfunction in patients with subcortical vascular cognitive impairment.Cerebrovascular disease (CVD) and amyloid burden are the most frequent pathologies in subjects with cognitive impairment. However, the relationship between CVD, amyloid burden, and cognition are largely unknown. We aimed to evaluate whether CVD (lacunes, white matter hyperintensities, and microbleeds) and amyloid burden (Pittsburgh compound B [PiB] retention ratio) contribute to cognitive impairment independently or interactively. We recruited 136 patients with subcortical vascular cognitive impairment who underwent magnetic resonance imaging, PiB-positron emission tomography, and neuropsychological testing. The number of lacunes was associated with memory, frontal dysfunctions, and disease severity. The volume of white matter hyperintensities and the PiB retention ratio were associated only with memory dysfunction. There was no direct correlation between CVD markers and PiB retention ratio except that the number of lacunes was negatively correlated with the PiB retention ratio. In addition, there were no interactive effects of CVD and PiB retention ratio on cognition. Our findings suggest that CVD and amyloid burden contribute independently and not interactively to specific patterns of cognitive dysfunction in patients with subcortical vascular cognitive impairment.
Abstract Cerebrovascular disease (CVD) and amyloid burden are the most frequent pathologies in subjects with cognitive impairment. However, the relationship between CVD, amyloid burden, and cognition are largely unknown. We aimed to evaluate whether CVD (lacunes, white matter hyperintensities, and microbleeds) and amyloid burden (Pittsburgh compound B [PiB] retention ratio) contribute to cognitive impairment independently or interactively. We recruited 136 patients with subcortical vascular cognitive impairment who underwent magnetic resonance imaging, PiB–positron emission tomography, and neuropsychological testing. The number of lacunes was associated with memory, frontal dysfunctions, and disease severity. The volume of white matter hyperintensities and the PiB retention ratio were associated only with memory dysfunction. There was no direct correlation between CVD markers and PiB retention ratio except that the number of lacunes was negatively correlated with the PiB retention ratio. In addition, there were no interactive effects of CVD and PiB retention ratio on cognition. Our findings suggest that CVD and amyloid burden contribute independently and not interactively to specific patterns of cognitive dysfunction in patients with subcortical vascular cognitive impairment.
Author Shin, Ji Soo
Kim, Jae Seung
Ye, Byoung Seok
Kim, Sook Hui
Kim, Changsoo
Kim, Hee Jin
Ewers, Michael
Yoon, Cindy W.
Kim, Sung Tae
Lee, Jong Min
Lee, Kyung-Han
Kim, Geon Ha
Jeon, Seun
Lee, Jae-Hong
Noh, Young
Cho, Hanna
Oh, Seung Jun
Kim, Chi Hun
Choe, Yearn Seong
Seo, Sang Won
Werring, David J.
Park, Jae-Hyun
Na, Duk L.
Weiner, Michael W.
AuthorAffiliation e Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
i Pfizer Korea, Seoul, South Korea
m Institute for Stroke and Dementia Research, Ludwig-Maximilians-University, Munich, Germany
p Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
o Center for Imaging of Neurodegenerative Diseases, Department of Veterans Affairs Medical Center, San Francisco, CA, USA
a Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
k Department of Neurology, Gachon University Gil Medical Center, Incheon, South Korea
n Department of Medicine, Radiology and Psychiatry, University of California, San Francisco, San Francisco, CA, USA
j Department of Psychology, University of Cambridge, CB2 3EB, UK
h Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
q Department of Brain Repair and Reh
AuthorAffiliation_xml – name: j Department of Psychology, University of Cambridge, CB2 3EB, UK
– name: k Department of Neurology, Gachon University Gil Medical Center, Incheon, South Korea
– name: f Department of Biomedical Engineering, Hanyang University, Seoul, South Korea
– name: l Department of Neurology, Inha University School of Medicine, Incheon, Korea
– name: o Center for Imaging of Neurodegenerative Diseases, Department of Veterans Affairs Medical Center, San Francisco, CA, USA
– name: m Institute for Stroke and Dementia Research, Ludwig-Maximilians-University, Munich, Germany
– name: n Department of Medicine, Radiology and Psychiatry, University of California, San Francisco, San Francisco, CA, USA
– name: d Department of Neurology, Ewha Womans University Mokdong Hospital, Ewha Womans University School of Medicine, Seoul, South Korea
– name: q Department of Brain Repair and Rehabilitation, UCL Institute of Neurology, Queen Square, London, UK
– name: b Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, South Korea
– name: p Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
– name: c Department of Neurology, Konkuk University Hospital, Konkuk University School of Medicine, Seoul, South Korea
– name: g Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
– name: i Pfizer Korea, Seoul, South Korea
– name: e Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
– name: a Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
– name: h Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
Author_xml – sequence: 1
  givenname: Jae-Hyun
  surname: Park
  fullname: Park, Jae-Hyun
  organization: Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
– sequence: 2
  givenname: Sang Won
  surname: Seo
  fullname: Seo, Sang Won
  email: sangwonseo@empal.com
  organization: Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
– sequence: 3
  givenname: Changsoo
  surname: Kim
  fullname: Kim, Changsoo
  organization: Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, South Korea
– sequence: 4
  givenname: Sook Hui
  surname: Kim
  fullname: Kim, Sook Hui
  organization: Department of Neurology, Konkuk University Hospital, Konkuk University School of Medicine, Seoul, South Korea
– sequence: 5
  givenname: Geon Ha
  surname: Kim
  fullname: Kim, Geon Ha
  organization: Department of Neurology, Ewha Womans University Mokdong Hospital, Ewha Womans University School of Medicine, Seoul, South Korea
– sequence: 6
  givenname: Sung Tae
  surname: Kim
  fullname: Kim, Sung Tae
  organization: Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
– sequence: 7
  givenname: Seun
  surname: Jeon
  fullname: Jeon, Seun
  organization: Department of Biomedical Engineering, Hanyang University, Seoul, South Korea
– sequence: 8
  givenname: Jong Min
  surname: Lee
  fullname: Lee, Jong Min
  organization: Department of Biomedical Engineering, Hanyang University, Seoul, South Korea
– sequence: 9
  givenname: Seung Jun
  surname: Oh
  fullname: Oh, Seung Jun
  organization: Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
– sequence: 10
  givenname: Jae Seung
  surname: Kim
  fullname: Kim, Jae Seung
  organization: Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
– sequence: 11
  givenname: Yearn Seong
  surname: Choe
  fullname: Choe, Yearn Seong
  organization: Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
– sequence: 12
  givenname: Kyung-Han
  surname: Lee
  fullname: Lee, Kyung-Han
  organization: Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
– sequence: 13
  givenname: Ji Soo
  surname: Shin
  fullname: Shin, Ji Soo
  organization: Pfizer Korea, Seoul, South Korea
– sequence: 14
  givenname: Chi Hun
  surname: Kim
  fullname: Kim, Chi Hun
  organization: Department of Psychology, University of Cambridge, CB2 3EB, UK
– sequence: 15
  givenname: Young
  surname: Noh
  fullname: Noh, Young
  organization: Department of Neurology, Gachon University Gil Medical Center, Incheon, South Korea
– sequence: 16
  givenname: Hanna
  surname: Cho
  fullname: Cho, Hanna
  organization: Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
– sequence: 17
  givenname: Cindy W.
  surname: Yoon
  fullname: Yoon, Cindy W.
  organization: Department of Neurology, Inha University School of Medicine, Incheon, Korea
– sequence: 18
  givenname: Hee Jin
  surname: Kim
  fullname: Kim, Hee Jin
  organization: Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
– sequence: 19
  givenname: Byoung Seok
  surname: Ye
  fullname: Ye, Byoung Seok
  organization: Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
– sequence: 20
  givenname: Michael
  surname: Ewers
  fullname: Ewers, Michael
  organization: Institute for Stroke and Dementia Research, Ludwig-Maximilians-University, Munich, Germany
– sequence: 21
  givenname: Michael W.
  surname: Weiner
  fullname: Weiner, Michael W.
  organization: Department of Medicine, Radiology and Psychiatry, University of California, San Francisco, San Francisco, CA, USA
– sequence: 22
  givenname: Jae-Hong
  surname: Lee
  fullname: Lee, Jae-Hong
  organization: Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
– sequence: 23
  givenname: David J.
  surname: Werring
  fullname: Werring, David J.
  organization: Department of Brain Repair and Rehabilitation, UCL Institute of Neurology, Queen Square, London, UK
– sequence: 24
  givenname: Duk L.
  surname: Na
  fullname: Na, Duk L.
  email: dukna@skku.edu
  organization: Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23932881$$D View this record in MEDLINE/PubMed
BookMark eNqNksFrFDEUxgep2G31X5AcPHjZNckkkwlIQWurQsGDCt5CJnmzzTqTrMnMyl79y5vpbostiHtKQr73ex_vfSfFkQ8eiuIVwQuCSfVmtfAwxtC40Oml88sFxaRc4GqBafWkmBHO6zlhUhwVM0ykmDNe4-PiJKUVxlgwUT0rjmkpS1rXZFb8uWhbMENCoUUGIjQxbHQyY6cjsi6BToC0t0j32y44ixoYNGrGaMGj4JEJS-8Gl2_OozQ2q1vWbzdcTy8T4uCM7tA9cq_fAHL9WrvYgx-eF09b3SV4sT9Pi--XF9_OP82vvnz8fP7uam4qxoY5tVK0ppSskobj2pSGUyKpNEZYRljbCmEaYY2kdSUqrksuKkkkJjarNWblaXG2467HpgdrcuuoO7WOrtdxq4J26uGPd9dqGTaK10xiPgFe7wEx_BohDap3yUDXaQ9hTIpwUok8WSn-L2WsZJTVXGbpy79t3fu521EWvN8JTAwpRWiVcYOehp5duk4RrKZgqJV6GAw1BUPhSuVgZMjbR5C7PgeWX-7KIS9o4yCqZBx4A9bFvHJlgzsUdPYIZDrnp5D8hC2kVRijzyFQRCWqsPo6RXhKMCkxprX4kQEf_g043McNR9IOug
CitedBy_id crossref_primary_10_3233_JAD_150841
crossref_primary_10_1038_s41598_020_75664_8
crossref_primary_10_1038_srep20709
crossref_primary_10_12779_dnd_2024_23_4_212
crossref_primary_10_3174_ajnr_A4956
crossref_primary_10_1007_s00259_019_04498_y
crossref_primary_10_3233_JAD_200079
crossref_primary_10_1111_cns_12424
crossref_primary_10_1212_WNL_0000000000011833
crossref_primary_10_1093_brain_aww183
crossref_primary_10_3233_JAD_221207
crossref_primary_10_3233_JAD_221209
crossref_primary_10_1016_j_jstrokecerebrovasdis_2018_02_065
crossref_primary_10_3390_brainsci13020218
crossref_primary_10_1080_1028415X_2023_2166436
crossref_primary_10_1186_s12877_017_0522_4
crossref_primary_10_1038_s41598_020_76102_5
crossref_primary_10_1093_brain_aww148
crossref_primary_10_3233_ADR_230040
crossref_primary_10_1016_j_jalz_2017_01_026
crossref_primary_10_1212_WNL_0000000000011029
crossref_primary_10_3233_JAD_230898
crossref_primary_10_3233_JAD_190651
crossref_primary_10_23838_pfm_2021_00023
crossref_primary_10_1080_13825585_2019_1628916
crossref_primary_10_1212_WNL_0000000000001705
crossref_primary_10_1002_gps_5900
crossref_primary_10_1155_2020_4347676
crossref_primary_10_1371_journal_pone_0138180
crossref_primary_10_1016_j_arr_2024_102247
crossref_primary_10_3233_JAD_160474
crossref_primary_10_1002_alz_14328
crossref_primary_10_3233_JAD_180027
crossref_primary_10_3233_JAD_201525
crossref_primary_10_1016_j_biopsych_2023_09_003
crossref_primary_10_1007_s00259_019_04314_7
crossref_primary_10_1016_j_jalz_2019_08_190
crossref_primary_10_1111_ene_12645
crossref_primary_10_1016_j_nbd_2017_06_011
crossref_primary_10_1016_j_neurobiolaging_2017_12_004
crossref_primary_10_1186_s12883_015_0459_1
crossref_primary_10_1016_j_bbadis_2015_12_010
crossref_primary_10_1111_ene_15159
crossref_primary_10_1186_s13195_018_0413_8
crossref_primary_10_1007_s12011_024_04326_x
crossref_primary_10_1161_STROKEAHA_115_007958
crossref_primary_10_3233_JAD_240196
crossref_primary_10_3233_JAD_180554
crossref_primary_10_1038_s41598_017_16236_1
crossref_primary_10_1016_j_neurobiolaging_2023_08_005
crossref_primary_10_1016_j_neurobiolaging_2017_03_010
crossref_primary_10_3233_JAD_230675
crossref_primary_10_1001_jamaneurol_2018_1123
crossref_primary_10_1016_j_cpet_2022_09_007
crossref_primary_10_1212_WNL_0000000000008315
crossref_primary_10_3389_fnagi_2023_1168062
crossref_primary_10_1212_WNL_0000000000002097
crossref_primary_10_1177_0271678X21990980
crossref_primary_10_1371_journal_pone_0131893
crossref_primary_10_18632_oncotarget_21855
crossref_primary_10_1161_STROKEAHA_114_006571
crossref_primary_10_3389_fnagi_2016_00014
crossref_primary_10_3390_ijms231810490
crossref_primary_10_1007_s00401_017_1717_7
crossref_primary_10_1002_alz_13607
crossref_primary_10_1186_s13195_021_00911_7
crossref_primary_10_1161_STROKEAHA_115_010528
crossref_primary_10_3389_fneur_2022_913241
Cites_doi 10.1002/ana.20630
10.1016/j.neuropsychologia.2011.10.010
10.1097/00005072-199702000-00007
10.3346/jkms.2010.25.7.1071
10.1523/JNEUROSCI.2462-12.2012
10.1161/STROKEAHA.106.477315
10.1093/cercor/bhr172
10.1002/ana.20009
10.1001/jamaneurol.2013.1321
10.1161/STROKEAHA.107.484147
10.1001/jama.1997.03540340047031
10.1093/brain/awh253
10.1016/j.neurobiolaging.2011.10.001
10.1016/S1474-4422(02)00190-4
10.1001/archneur.1993.00540080076020
10.1212/WNL.0b013e31821d752f
10.1016/j.nbd.2009.04.009
10.1016/j.neurobiolaging.2011.10.002
10.1212/WNL.0b013e3181c33afb
10.33549/physiolres.932186
10.1212/01.WNL.0000118211.78503.F5
10.1002/ima.20277
10.1016/j.neurobiolaging.2013.01.002
10.1093/brain/awr169
10.1002/ana.21009
10.1111/j.1552-6569.2010.00527.x
10.1093/brain/awl385
10.1001/archneur.63.2.246
10.3389/fnagi.2013.00017
10.1161/STROKEAHA.107.491795
10.1136/jnnp.2008.160440
10.1007/s00401-001-0493-5
10.1076/jcen.21.1.127.942
10.1212/WNL.51.6.1689
10.1155/2011/826862
10.1016/S1474-4422(09)70013-4
10.1093/geront/9.3_Part_1.179
10.1001/archneurol.2010.284
10.1001/2013.jamaneurol.405
10.1002/ana.410190306
10.1212/01.wnl.0000172913.88973.0d
10.1002/ana.23830
10.1161/STROKEAHA.111.620179
10.1212/WNL.0b013e318221acee
10.1212/WNL.0b013e31828ab35d
ContentType Journal Article
Copyright 2014 Elsevier Inc.
Elsevier Inc.
Copyright © 2014 Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2014 Elsevier Inc.
– notice: Elsevier Inc.
– notice: Copyright © 2014 Elsevier Inc. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7TK
5PM
DOI 10.1016/j.neurobiolaging.2013.06.026
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Neurosciences Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Neurosciences Abstracts
DatabaseTitleList

MEDLINE - Academic
MEDLINE

Neurosciences Abstracts

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1558-1497
EndPage 260
ExternalDocumentID PMC5849054
23932881
10_1016_j_neurobiolaging_2013_06_026
S019745801300287X
1_s2_0_S019745801300287X
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: NIA NIH HHS
  grantid: P50 AG023501
GroupedDBID ---
--K
--M
-~X
.1-
.FO
.GJ
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
29N
4.4
457
4G.
53G
5RE
5VS
7-5
71M
8P~
9JM
9JO
AABNK
AADFP
AAEDT
AAEDW
AAGJA
AAGUQ
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXLA
AAXUO
AAYWO
ABBQC
ABCQJ
ABFNM
ABFRF
ABGSF
ABIVO
ABJNI
ABLJU
ABMAC
ABMZM
ABOYX
ABUDA
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACIUM
ACRLP
ACRPL
ACVFH
ACXNI
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADUVX
AEBSH
AEFWE
AEHWI
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGRDE
AGUBO
AGWIK
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRLJ
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HDW
HMK
HMO
HMQ
HVGLF
HZ~
IHE
J1W
KOM
LX8
M29
M2V
M41
MO0
MOBAO
MVM
N9A
O-L
O9-
OAUVE
OD~
OKEIE
OO0
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SNS
SPCBC
SSB
SSH
SSN
SSU
SSY
SSZ
T5K
WUQ
Z5R
ZGI
~G-
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
RIG
AADPK
AAIAV
ABLVK
ABYKQ
AFYLN
AJBFU
DOVZS
EFLBG
LCYCR
AAYXX
AGRNS
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7TK
ACLOT
~HD
5PM
ID FETCH-LOGICAL-c644t-2d97fc39469c508c3c521929cc7d414ff77cb7dc9286765a357691901d508a043
IEDL.DBID AIKHN
ISSN 0197-4580
1558-1497
IngestDate Thu Aug 21 14:33:13 EDT 2025
Sun Sep 28 09:47:08 EDT 2025
Fri Sep 05 07:46:11 EDT 2025
Thu Apr 03 07:04:36 EDT 2025
Thu Apr 24 23:02:20 EDT 2025
Tue Jul 01 01:28:08 EDT 2025
Fri Feb 23 02:27:32 EST 2024
Sun Feb 23 10:19:38 EST 2025
Tue Aug 26 16:35:05 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords White matter hyperintensity
Microbleed
Pittsburgh compound B
Amyloid
Cognition
Lacune
Cerebrovascular disease
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
Copyright © 2014 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c644t-2d97fc39469c508c3c521929cc7d414ff77cb7dc9286765a357691901d508a043
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
Alternate corresponding author at: Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon-dong, Kangnam-ku, Seoul 135-710, South Korea. Tel.: +82 2 3410 3591 ×99; fax: +82 2 3410 0052.
OpenAccessLink http://doi.org/10.1016/j.neurobiolaging.2013.06.026
PMID 23932881
PQID 1443424859
PQPubID 23479
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5849054
proquest_miscellaneous_1516739397
proquest_miscellaneous_1443424859
pubmed_primary_23932881
crossref_citationtrail_10_1016_j_neurobiolaging_2013_06_026
crossref_primary_10_1016_j_neurobiolaging_2013_06_026
elsevier_sciencedirect_doi_10_1016_j_neurobiolaging_2013_06_026
elsevier_clinicalkeyesjournals_1_s2_0_S019745801300287X
elsevier_clinicalkey_doi_10_1016_j_neurobiolaging_2013_06_026
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-01-01
PublicationDateYYYYMMDD 2014-01-01
PublicationDate_xml – month: 01
  year: 2014
  text: 2014-01-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Neurobiology of aging
PublicationTitleAlternate Neurobiol Aging
PublicationYear 2014
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Lee, Fletcher, Martinez, Ortega, Zozulya, Kim, Tran, Buonocore, Carmichael, DeCarli (bib28) 2009; 73
Marchant, Reed, Sanossian, Madison, Kriger, Dhada, Mack, Decarli, Weiner, Mungas, Chui, Jagust (bib31) 2013; 70
Cummings (bib10) 1993; 50
Hedden, Oh, Younger, Patel (bib17) 2013; 80
Roman, Erkinjuntti, Wallin, Pantoni, Chui (bib37) 2002; 1
Jeon, Yoon, Park, Seo, Kim, Kim, Kim, Na, Lee (bib21) 2011; 21
Jablonski, Maciejewski, Januszewski, Ulamek, Pluta (bib19) 2011; 60
Kim, Park, Ahn, Seo, Lee, Kim, Han, Na (bib25) 2011; 21
Nagy, Esiri, Jobst, Morris, King, McDonald, Joachim, Litchfield, Barnetson, Smith (bib33) 1997; 56
Schmidt, Ropele, Enzinger, Petrovic, Smith, Schmidt, Matthews, Fazekas (bib39) 2005; 58
Brun, Englund (bib5) 1986; 19
Jokinen, Gouw, Madureira, Ylikoski, van Straaten, van der Flier, Barkhof, Scheltens, Fazekas, Schmidt, Verdelho, Ferro, Pantoni, Inzitari, Erkinjuntti (bib22) 2011; 76
Wright, Festa, Paik, Schmiedigen, Brown, Yoshita, DeCarli, Sacco, Stern (bib45) 2008; 39
Ahn, Chin, Park, Lee, Suh, Seo, Na (bib1) 2010; 25
Goodkin, Rooney, Sloan, Bacchetti, Gee, Vermathen, Waubant, Abundo, Majumdar, Nelson, Weiner (bib12) 1998; 51
Gurol, Viswanathan, Gidicsin, Hedden, Martinez-Ramirez, Dumas, Vashkevich, Ayres, Auriel, van Etten, Becker, Carmasin, Schwab, Rosand, Johnson, Greenberg (bib14) 2013; 73
Reed, Mungas, Kramer, Ellis, Vinters, Zarow, Jagust, Chui (bib36) 2007; 130
Werring, Frazer, Coward, Losseff, Watt, Cipolotti, Brown, Jager (bib44) 2004; 127
Seo, Hwa Lee, Kim, Chin, Sun Cho, Na, Yoon (bib41) 2007; 38
Snowdon, Greiner, Mortimer, Riley, Greiner, Markesbery (bib43) 1997; 277
Carey, Kramer, Josephson, Mungas, Reed, Schuff, Weiner, Chui (bib6) 2008; 39
Zekry, Duyckaerts, Moulias, Belmin, Geoffre, Herrmann, Hauw (bib46) 2002; 103
Reed, Marchant, Jagust, DeCarli, Mack, Chui (bib35) 2012; 33
Marchant, Reed, DeCarli, Madison, Weiner, Chui, Jagust (bib30) 2012; 33
Provenzano, Muraskin, Tosto, Narkhede, Wasserman, Griffith, Guzman, Meier, Zimmerman, Brickman, Alzheimer's Disease Neuroimaging Initiative (bib34) 2013; 70
Ahn, Seo, Chin, Suh, Lee, Kim, Im, Lee, Lee, Heilman, Na (bib2) 2011; 49
Carmichael, Schwarz, Drucker, Fletcher, Harvey, Beckett, Jack, Weiner, DeCarli, Alzheimer's Disease Neuroimaging Initiative (bib7) 2010; 67
Duering, Zieren, Herve, Jouvent, Reyes, Peters, Pachai, Opherk, Chabriat, Dichgans (bib11) 2011; 134
Kim, Kang, Kim, Kim, Jeon, Lee, Oh, Kim, Choe, Lee, Noh, Cho, Yoon, Chin, Cummings, Lee, Na, Seo (bib24) 2013; 34
Schneider, Wilson, Bienias, Evans, Bennett (bib40) 2004; 62
Kim, Na (bib23) 1999; 21
Jellinger (bib20) 2013; 5
Hedden, Van Dijk, Shire, Sperling, Johnson, Buckner (bib16) 2012; 22
Mungas, Harvey, Reed, Jagust, DeCarli, Beckett, Mack, Kramer, Weiner, Schuff, Chui (bib32) 2005; 65
Rutten-Jacobs, de Leeuw, Geurts-van Bon, Gordinou de Gouberville, Schepens-Franke, Dederen, Spliet, Wesseling, Kiliaan (bib38) 2011; 2011
Au, Massaro, Wolf, Young, Beiser, Seshadri, D'Agostino, DeCarli (bib3) 2006; 63
Hiltunen, Makinen, Peraniemi, Sivenius, van Groen, Soininen, Jolkkonen (bib18) 2009; 35
Choi, Lee, Han, Woo, Kim, Choi, Kwon, Han, Shin, Lee, Chung, Kim (bib8) 2011; 42
Benisty, Gouw, Porcher, Madureira, Hernandez, Poggesi, van der Flier, Van Straaten, Verdelho, Ferro, Pantoni, Inzitari, Barkhof, Fazekas, Chabriat (bib4) 2009; 80
Chui, Zarow, Mack, Ellis, Zheng, Jagust, Mungas, Reed, Kramer, Decarli, Weiner, Vinters (bib9) 2006; 60
Klunk, Engler, Nordberg, Wang, Blomqvist, Holt, Bergstrom, Savitcheva, Huang, Estrada, Ausen, Debnath, Barletta, Price, Sandell, Lopresti, Wall, Koivisto, Antoni, Mathis, Langstrom (bib26) 2004; 55
Lawton, Brody (bib27) 1969; 9
Greenberg, Vernooij, Cordonnier, Viswanathan, Al-Shahi Salman, Warach, Launer, Van Buchem, Breteler (bib13) 2009; 8
Hedden, Mormino, Amariglio, Younger, Schultz, Becker, Buckner, Johnson, Sperling, Rentz (bib15) 2012; 32
Lee, Kim, Kim, Seo, Park, Oh, Kim, Cheong, Na (bib29) 2011; 77
Chui (10.1016/j.neurobiolaging.2013.06.026_bib9) 2006; 60
Snowdon (10.1016/j.neurobiolaging.2013.06.026_bib43) 1997; 277
Roman (10.1016/j.neurobiolaging.2013.06.026_bib37) 2002; 1
Ahn (10.1016/j.neurobiolaging.2013.06.026_bib2) 2011; 49
Carmichael (10.1016/j.neurobiolaging.2013.06.026_bib7) 2010; 67
Brun (10.1016/j.neurobiolaging.2013.06.026_bib5) 1986; 19
Lawton (10.1016/j.neurobiolaging.2013.06.026_bib27) 1969; 9
Reed (10.1016/j.neurobiolaging.2013.06.026_bib35) 2012; 33
Hedden (10.1016/j.neurobiolaging.2013.06.026_bib16) 2012; 22
Duering (10.1016/j.neurobiolaging.2013.06.026_bib11) 2011; 134
Werring (10.1016/j.neurobiolaging.2013.06.026_bib44) 2004; 127
Schmidt (10.1016/j.neurobiolaging.2013.06.026_bib39) 2005; 58
Gurol (10.1016/j.neurobiolaging.2013.06.026_bib14) 2013; 73
Mungas (10.1016/j.neurobiolaging.2013.06.026_bib32) 2005; 65
Provenzano (10.1016/j.neurobiolaging.2013.06.026_bib34) 2013; 70
Jeon (10.1016/j.neurobiolaging.2013.06.026_bib21) 2011; 21
Benisty (10.1016/j.neurobiolaging.2013.06.026_bib4) 2009; 80
Reed (10.1016/j.neurobiolaging.2013.06.026_bib36) 2007; 130
Zekry (10.1016/j.neurobiolaging.2013.06.026_bib46) 2002; 103
Schneider (10.1016/j.neurobiolaging.2013.06.026_bib40) 2004; 62
Au (10.1016/j.neurobiolaging.2013.06.026_bib3) 2006; 63
Jablonski (10.1016/j.neurobiolaging.2013.06.026_bib19) 2011; 60
Jellinger (10.1016/j.neurobiolaging.2013.06.026_bib20) 2013; 5
Kim (10.1016/j.neurobiolaging.2013.06.026_bib24) 2013; 34
Wright (10.1016/j.neurobiolaging.2013.06.026_bib45) 2008; 39
Rutten-Jacobs (10.1016/j.neurobiolaging.2013.06.026_bib38) 2011; 2011
Marchant (10.1016/j.neurobiolaging.2013.06.026_bib31) 2013; 70
Cummings (10.1016/j.neurobiolaging.2013.06.026_bib10) 1993; 50
Jokinen (10.1016/j.neurobiolaging.2013.06.026_bib22) 2011; 76
Lee (10.1016/j.neurobiolaging.2013.06.026_bib29) 2011; 77
Hedden (10.1016/j.neurobiolaging.2013.06.026_bib15) 2012; 32
Nagy (10.1016/j.neurobiolaging.2013.06.026_bib33) 1997; 56
Seo (10.1016/j.neurobiolaging.2013.06.026_bib41) 2007; 38
Kim (10.1016/j.neurobiolaging.2013.06.026_bib23) 1999; 21
Goodkin (10.1016/j.neurobiolaging.2013.06.026_bib12) 1998; 51
Lee (10.1016/j.neurobiolaging.2013.06.026_bib28) 2009; 73
Greenberg (10.1016/j.neurobiolaging.2013.06.026_bib13) 2009; 8
Hiltunen (10.1016/j.neurobiolaging.2013.06.026_bib18) 2009; 35
Marchant (10.1016/j.neurobiolaging.2013.06.026_bib30) 2012; 33
Choi (10.1016/j.neurobiolaging.2013.06.026_bib8) 2011; 42
Klunk (10.1016/j.neurobiolaging.2013.06.026_bib26) 2004; 55
Carey (10.1016/j.neurobiolaging.2013.06.026_bib6) 2008; 39
Hedden (10.1016/j.neurobiolaging.2013.06.026_bib17) 2013; 80
Ahn (10.1016/j.neurobiolaging.2013.06.026_bib1) 2010; 25
Kim (10.1016/j.neurobiolaging.2013.06.026_bib25) 2011; 21
References_xml – volume: 80
  start-page: 1341
  year: 2013
  end-page: 1348
  ident: bib17
  article-title: Meta-analysis of amyloid-cognition relations in cognitively normal older adults
  publication-title: Neurology
– volume: 76
  start-page: 1872
  year: 2011
  end-page: 1878
  ident: bib22
  article-title: Incident lacunes influence cognitive decline: the LADIS study
  publication-title: Neurology
– volume: 60
  start-page: 677
  year: 2006
  end-page: 687
  ident: bib9
  article-title: Cognitive impact of subcortical vascular and Alzheimer's disease pathology
  publication-title: Ann. Neurol.
– volume: 127
  start-page: 2265
  year: 2004
  ident: bib44
  article-title: Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI
  publication-title: Brain
– volume: 65
  start-page: 565
  year: 2005
  end-page: 571
  ident: bib32
  article-title: Longitudinal volumetric MRI change and rate of cognitive decline
  publication-title: Neurology
– volume: 134
  start-page: 2366
  year: 2011
  end-page: 2375
  ident: bib11
  article-title: Strategic role of frontal white matter tracts in vascular cognitive impairment: a voxel-based lesion-symptom mapping study in CADASIL
  publication-title: Brain
– volume: 21
  start-page: 317
  year: 2011
  end-page: 324
  ident: bib25
  article-title: Voxel-based analysis of diffusion tensor imaging in patients with subcortical vascular cognitive impairment: correlates with cognitive and motor deficits
  publication-title: J. Neuroimaging
– volume: 103
  start-page: 481
  year: 2002
  end-page: 487
  ident: bib46
  article-title: Degenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly
  publication-title: Acta Neuropathol.
– volume: 56
  start-page: 165
  year: 1997
  end-page: 170
  ident: bib33
  article-title: The effects of additional pathology on the cognitive deficit in Alzheimer disease
  publication-title: J. Neuropathol. Exp. Neurol.
– volume: 5
  start-page: 17
  year: 2013
  ident: bib20
  article-title: Pathology and pathogenesis of vascular cognitive impairment-a critical update
  publication-title: Front Aging Neurosci.
– volume: 130
  start-page: 731
  year: 2007
  end-page: 739
  ident: bib36
  article-title: Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease
  publication-title: Brain
– volume: 73
  start-page: 1722
  year: 2009
  end-page: 1728
  ident: bib28
  article-title: Regional pattern of white matter microstructural changes in normal aging, MCI, and AD
  publication-title: Neurology
– volume: 39
  start-page: 800
  year: 2008
  end-page: 805
  ident: bib45
  article-title: White matter hyperintensities and subclinical infarction: associations with psychomotor speed and cognitive flexibility
  publication-title: Stroke
– volume: 49
  start-page: 3931
  year: 2011
  end-page: 3945
  ident: bib2
  article-title: The cortical neuroanatomy of neuropsychological deficits in mild cognitive impairment and Alzheimer's disease: a surface-based morphometric analysis
  publication-title: Neuropsychologia
– volume: 35
  start-page: 103
  year: 2009
  end-page: 113
  ident: bib18
  article-title: Focal cerebral ischemia in rats alters APP processing and expression of Abeta peptide degrading enzymes in the thalamus
  publication-title: Neurobiol. Dis.
– volume: 21
  start-page: 193
  year: 2011
  end-page: 200
  ident: bib21
  article-title: Fully automated pipeline for quantification and localization of white matter hyperintensity in brain magnetic resonance image
  publication-title: Int. J. Imag. Syst. Tech.
– volume: 22
  start-page: 1038
  year: 2012
  end-page: 1051
  ident: bib16
  article-title: Failure to modulate attentional control in advanced aging linked to white matter pathology
  publication-title: Cereb. Cortex
– volume: 80
  start-page: 478
  year: 2009
  end-page: 483
  ident: bib4
  article-title: Location of lacunar infarcts correlates with cognition in a sample of non-disabled subjects with age-related white-matter changes: the LADIS study
  publication-title: J. Neurol. Neurosurg. Psychiatry
– volume: 277
  start-page: 813
  year: 1997
  end-page: 817
  ident: bib43
  article-title: Brain infarction and the clinical expression of Alzheimer disease. The Nun Study
  publication-title: JAMA
– volume: 19
  start-page: 253
  year: 1986
  end-page: 262
  ident: bib5
  article-title: A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study
  publication-title: Ann. Neurol.
– volume: 39
  start-page: 397
  year: 2008
  end-page: 402
  ident: bib6
  article-title: Subcortical lacunes are associated with executive dysfunction in cognitively normal elderly
  publication-title: Stroke
– volume: 42
  start-page: 2595
  year: 2011
  end-page: 2604
  ident: bib8
  article-title: Synergistic memory impairment through the interaction of chronic cerebral hypoperfusion and amlyloid toxicity in a rat model
  publication-title: Stroke
– volume: 38
  start-page: 1949
  year: 2007
  end-page: 1951
  ident: bib41
  article-title: Clinical significance of microbleeds in subcortical vascular dementia
  publication-title: Stroke
– volume: 9
  start-page: 179
  year: 1969
  end-page: 186
  ident: bib27
  article-title: Assessment of older people: self-maintaining and instrumental activities of daily living
  publication-title: Gerontologist
– volume: 32
  start-page: 16233
  year: 2012
  end-page: 16242
  ident: bib15
  article-title: Cognitive profile of amyloid burden and white matter hyperintensities in cognitively normal older adults
  publication-title: J. Neurosci.
– volume: 70
  start-page: 455
  year: 2013
  end-page: 461
  ident: bib34
  article-title: White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?
  publication-title: JAMA Neurol.
– volume: 34
  start-page: 1913
  year: 2013
  end-page: 1920
  ident: bib24
  article-title: The effects of small vessel disease and amyloid burden on neuropsychiatric symptoms: a study among patients with subcortical vascular cognitive impairments
  publication-title: Neurobiology of Aging
– volume: 50
  start-page: 873
  year: 1993
  end-page: 880
  ident: bib10
  article-title: Frontal-subcortical circuits and human behavior
  publication-title: Arch. Neurol.
– volume: 21
  start-page: 127
  year: 1999
  end-page: 133
  ident: bib23
  article-title: Normative data on the Korean version of the Boston Naming Test
  publication-title: J. Clin. Exp. Neuropsychol.
– volume: 70
  start-page: 488
  year: 2013
  end-page: 495
  ident: bib31
  article-title: The aging brain and cognition: contribution of vascular injury and abeta to mild cognitive dysfunction
  publication-title: JAMA Neurol.
– volume: 58
  start-page: 610
  year: 2005
  end-page: 616
  ident: bib39
  article-title: White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study
  publication-title: Ann. Neurol.
– volume: 51
  start-page: 1689
  year: 1998
  end-page: 1697
  ident: bib12
  article-title: A serial study of new MS lesions and the white matter from which they arise
  publication-title: Neurology
– volume: 60
  start-page: S113
  year: 2011
  end-page: S119
  ident: bib19
  article-title: One year follow up in ischemic brain injury and the role of Alzheimer factors
  publication-title: Physiol. Res.
– volume: 2011
  start-page: 826862
  year: 2011
  ident: bib38
  article-title: White matter lesions are not related to beta-amyloid deposition in an autopsy-based study
  publication-title: Curr. Gerontol. Geriatr. Res.
– volume: 63
  start-page: 246
  year: 2006
  end-page: 250
  ident: bib3
  article-title: Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study
  publication-title: Arch. Neurol.
– volume: 67
  start-page: 1370
  year: 2010
  end-page: 1378
  ident: bib7
  article-title: Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative
  publication-title: Arch. Neurol.
– volume: 55
  start-page: 306
  year: 2004
  end-page: 319
  ident: bib26
  article-title: Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
  publication-title: Ann. Neurol.
– volume: 33
  start-page: 1006.e1025
  year: 2012
  end-page: 1006.e1036
  ident: bib30
  article-title: Cerebrovascular disease, beta-amyloid, and cognition in aging
  publication-title: Neurobiol. Aging
– volume: 8
  start-page: 165
  year: 2009
  end-page: 174
  ident: bib13
  article-title: Cerebral microbleeds: a guide to detection and interpretation
  publication-title: Lancet Neurol.
– volume: 73
  start-page: 529
  year: 2013
  end-page: 536
  ident: bib14
  article-title: Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study
  publication-title: Ann. Neurol.
– volume: 33
  start-page: 1979
  year: 2012
  end-page: 1987
  ident: bib35
  article-title: Coronary risk correlates with cerebral amyloid deposition
  publication-title: Neurobiology of Aging
– volume: 25
  start-page: 1071
  year: 2010
  end-page: 1076
  ident: bib1
  article-title: Seoul Neuropsychological Screening Battery-dementia version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in dementia patients
  publication-title: J. Korean Med. Sci.
– volume: 1
  start-page: 426
  year: 2002
  end-page: 436
  ident: bib37
  article-title: Subcortical ischaemic vascular dementia
  publication-title: Lancet Neurol.
– volume: 62
  start-page: 1148
  year: 2004
  end-page: 1155
  ident: bib40
  article-title: Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology
  publication-title: Neurology
– volume: 77
  start-page: 18
  year: 2011
  end-page: 25
  ident: bib29
  article-title: Identification of pure subcortical vascular dementia using 11C-Pittsburgh compound B
  publication-title: Neurology
– volume: 58
  start-page: 610
  year: 2005
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib39
  article-title: White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study
  publication-title: Ann. Neurol.
  doi: 10.1002/ana.20630
– volume: 49
  start-page: 3931
  year: 2011
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib2
  article-title: The cortical neuroanatomy of neuropsychological deficits in mild cognitive impairment and Alzheimer's disease: a surface-based morphometric analysis
  publication-title: Neuropsychologia
  doi: 10.1016/j.neuropsychologia.2011.10.010
– volume: 56
  start-page: 165
  year: 1997
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib33
  article-title: The effects of additional pathology on the cognitive deficit in Alzheimer disease
  publication-title: J. Neuropathol. Exp. Neurol.
  doi: 10.1097/00005072-199702000-00007
– volume: 25
  start-page: 1071
  year: 2010
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib1
  article-title: Seoul Neuropsychological Screening Battery-dementia version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in dementia patients
  publication-title: J. Korean Med. Sci.
  doi: 10.3346/jkms.2010.25.7.1071
– volume: 32
  start-page: 16233
  year: 2012
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib15
  article-title: Cognitive profile of amyloid burden and white matter hyperintensities in cognitively normal older adults
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.2462-12.2012
– volume: 38
  start-page: 1949
  year: 2007
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib41
  article-title: Clinical significance of microbleeds in subcortical vascular dementia
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.106.477315
– volume: 22
  start-page: 1038
  year: 2012
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib16
  article-title: Failure to modulate attentional control in advanced aging linked to white matter pathology
  publication-title: Cereb. Cortex
  doi: 10.1093/cercor/bhr172
– volume: 55
  start-page: 306
  year: 2004
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib26
  article-title: Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
  publication-title: Ann. Neurol.
  doi: 10.1002/ana.20009
– volume: 70
  start-page: 455
  year: 2013
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib34
  article-title: White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?
  publication-title: JAMA Neurol.
  doi: 10.1001/jamaneurol.2013.1321
– volume: 39
  start-page: 800
  year: 2008
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib45
  article-title: White matter hyperintensities and subclinical infarction: associations with psychomotor speed and cognitive flexibility
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.107.484147
– volume: 277
  start-page: 813
  year: 1997
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib43
  article-title: Brain infarction and the clinical expression of Alzheimer disease. The Nun Study
  publication-title: JAMA
  doi: 10.1001/jama.1997.03540340047031
– volume: 127
  start-page: 2265
  year: 2004
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib44
  article-title: Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI
  publication-title: Brain
  doi: 10.1093/brain/awh253
– volume: 33
  start-page: 1006.e1025
  year: 2012
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib30
  article-title: Cerebrovascular disease, beta-amyloid, and cognition in aging
  publication-title: Neurobiol. Aging
  doi: 10.1016/j.neurobiolaging.2011.10.001
– volume: 1
  start-page: 426
  year: 2002
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib37
  article-title: Subcortical ischaemic vascular dementia
  publication-title: Lancet Neurol.
  doi: 10.1016/S1474-4422(02)00190-4
– volume: 50
  start-page: 873
  year: 1993
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib10
  article-title: Frontal-subcortical circuits and human behavior
  publication-title: Arch. Neurol.
  doi: 10.1001/archneur.1993.00540080076020
– volume: 76
  start-page: 1872
  year: 2011
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib22
  article-title: Incident lacunes influence cognitive decline: the LADIS study
  publication-title: Neurology
  doi: 10.1212/WNL.0b013e31821d752f
– volume: 35
  start-page: 103
  year: 2009
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib18
  article-title: Focal cerebral ischemia in rats alters APP processing and expression of Abeta peptide degrading enzymes in the thalamus
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2009.04.009
– volume: 33
  start-page: 1979
  year: 2012
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib35
  article-title: Coronary risk correlates with cerebral amyloid deposition
  publication-title: Neurobiology of Aging
  doi: 10.1016/j.neurobiolaging.2011.10.002
– volume: 73
  start-page: 1722
  year: 2009
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib28
  article-title: Regional pattern of white matter microstructural changes in normal aging, MCI, and AD
  publication-title: Neurology
  doi: 10.1212/WNL.0b013e3181c33afb
– volume: 60
  start-page: S113
  issue: suppl 1
  year: 2011
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib19
  article-title: One year follow up in ischemic brain injury and the role of Alzheimer factors
  publication-title: Physiol. Res.
  doi: 10.33549/physiolres.932186
– volume: 62
  start-page: 1148
  year: 2004
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib40
  article-title: Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology
  publication-title: Neurology
  doi: 10.1212/01.WNL.0000118211.78503.F5
– volume: 21
  start-page: 193
  year: 2011
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib21
  article-title: Fully automated pipeline for quantification and localization of white matter hyperintensity in brain magnetic resonance image
  publication-title: Int. J. Imag. Syst. Tech.
  doi: 10.1002/ima.20277
– volume: 34
  start-page: 1913
  year: 2013
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib24
  article-title: The effects of small vessel disease and amyloid burden on neuropsychiatric symptoms: a study among patients with subcortical vascular cognitive impairments
  publication-title: Neurobiology of Aging
  doi: 10.1016/j.neurobiolaging.2013.01.002
– volume: 134
  start-page: 2366
  year: 2011
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib11
  article-title: Strategic role of frontal white matter tracts in vascular cognitive impairment: a voxel-based lesion-symptom mapping study in CADASIL
  publication-title: Brain
  doi: 10.1093/brain/awr169
– volume: 60
  start-page: 677
  year: 2006
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib9
  article-title: Cognitive impact of subcortical vascular and Alzheimer's disease pathology
  publication-title: Ann. Neurol.
  doi: 10.1002/ana.21009
– volume: 21
  start-page: 317
  year: 2011
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib25
  article-title: Voxel-based analysis of diffusion tensor imaging in patients with subcortical vascular cognitive impairment: correlates with cognitive and motor deficits
  publication-title: J. Neuroimaging
  doi: 10.1111/j.1552-6569.2010.00527.x
– volume: 130
  start-page: 731
  year: 2007
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib36
  article-title: Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease
  publication-title: Brain
  doi: 10.1093/brain/awl385
– volume: 63
  start-page: 246
  year: 2006
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib3
  article-title: Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study
  publication-title: Arch. Neurol.
  doi: 10.1001/archneur.63.2.246
– volume: 5
  start-page: 17
  year: 2013
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib20
  article-title: Pathology and pathogenesis of vascular cognitive impairment-a critical update
  publication-title: Front Aging Neurosci.
  doi: 10.3389/fnagi.2013.00017
– volume: 39
  start-page: 397
  year: 2008
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib6
  article-title: Subcortical lacunes are associated with executive dysfunction in cognitively normal elderly
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.107.491795
– volume: 80
  start-page: 478
  year: 2009
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib4
  article-title: Location of lacunar infarcts correlates with cognition in a sample of non-disabled subjects with age-related white-matter changes: the LADIS study
  publication-title: J. Neurol. Neurosurg. Psychiatry
  doi: 10.1136/jnnp.2008.160440
– volume: 103
  start-page: 481
  year: 2002
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib46
  article-title: Degenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-001-0493-5
– volume: 21
  start-page: 127
  year: 1999
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib23
  article-title: Normative data on the Korean version of the Boston Naming Test
  publication-title: J. Clin. Exp. Neuropsychol.
  doi: 10.1076/jcen.21.1.127.942
– volume: 51
  start-page: 1689
  year: 1998
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib12
  article-title: A serial study of new MS lesions and the white matter from which they arise
  publication-title: Neurology
  doi: 10.1212/WNL.51.6.1689
– volume: 2011
  start-page: 826862
  year: 2011
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib38
  article-title: White matter lesions are not related to beta-amyloid deposition in an autopsy-based study
  publication-title: Curr. Gerontol. Geriatr. Res.
  doi: 10.1155/2011/826862
– volume: 8
  start-page: 165
  year: 2009
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib13
  article-title: Cerebral microbleeds: a guide to detection and interpretation
  publication-title: Lancet Neurol.
  doi: 10.1016/S1474-4422(09)70013-4
– volume: 9
  start-page: 179
  year: 1969
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib27
  article-title: Assessment of older people: self-maintaining and instrumental activities of daily living
  publication-title: Gerontologist
  doi: 10.1093/geront/9.3_Part_1.179
– volume: 67
  start-page: 1370
  year: 2010
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib7
  article-title: Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative
  publication-title: Arch. Neurol.
  doi: 10.1001/archneurol.2010.284
– volume: 70
  start-page: 488
  year: 2013
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib31
  article-title: The aging brain and cognition: contribution of vascular injury and abeta to mild cognitive dysfunction
  publication-title: JAMA Neurol.
  doi: 10.1001/2013.jamaneurol.405
– volume: 19
  start-page: 253
  year: 1986
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib5
  article-title: A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study
  publication-title: Ann. Neurol.
  doi: 10.1002/ana.410190306
– volume: 65
  start-page: 565
  year: 2005
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib32
  article-title: Longitudinal volumetric MRI change and rate of cognitive decline
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000172913.88973.0d
– volume: 73
  start-page: 529
  year: 2013
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib14
  article-title: Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study
  publication-title: Ann. Neurol.
  doi: 10.1002/ana.23830
– volume: 42
  start-page: 2595
  year: 2011
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib8
  article-title: Synergistic memory impairment through the interaction of chronic cerebral hypoperfusion and amlyloid toxicity in a rat model
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.111.620179
– volume: 77
  start-page: 18
  year: 2011
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib29
  article-title: Identification of pure subcortical vascular dementia using 11C-Pittsburgh compound B
  publication-title: Neurology
  doi: 10.1212/WNL.0b013e318221acee
– volume: 80
  start-page: 1341
  year: 2013
  ident: 10.1016/j.neurobiolaging.2013.06.026_bib17
  article-title: Meta-analysis of amyloid-cognition relations in cognitively normal older adults
  publication-title: Neurology
  doi: 10.1212/WNL.0b013e31828ab35d
SSID ssj0007476
Score 2.3916876
Snippet Cerebrovascular disease (CVD) and amyloid burden are the most frequent pathologies in subjects with cognitive impairment. However, the relationship between...
Abstract Cerebrovascular disease (CVD) and amyloid burden are the most frequent pathologies in subjects with cognitive impairment. However, the relationship...
SourceID pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 254
SubjectTerms Aged
Aged, 80 and over
Amyloid
Amyloid beta-Peptides - metabolism
Aniline Compounds
Brain - diagnostic imaging
Brain - pathology
Cerebrovascular disease
Cerebrovascular Disorders - complications
Cognition
Cognition Disorders - diagnosis
Cognition Disorders - etiology
Cognition Disorders - metabolism
Cognition Disorders - pathology
Female
Humans
Internal Medicine
Lacune
Magnetic Resonance Imaging
Male
Memory Disorders - diagnosis
Memory Disorders - etiology
Memory Disorders - pathology
Microbleed
Neurology
Neuropsychological Tests
Pittsburgh compound B
Positron-Emission Tomography
Thiazoles
White matter hyperintensity
Title Effects of cerebrovascular disease and amyloid beta burden on cognition in subjects with subcortical vascular cognitive impairment
URI https://www.clinicalkey.com/#!/content/1-s2.0-S019745801300287X
https://www.clinicalkey.es/playcontent/1-s2.0-S019745801300287X
https://dx.doi.org/10.1016/j.neurobiolaging.2013.06.026
https://www.ncbi.nlm.nih.gov/pubmed/23932881
https://www.proquest.com/docview/1443424859
https://www.proquest.com/docview/1516739397
https://pubmed.ncbi.nlm.nih.gov/PMC5849054
Volume 35
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Nb9MwFLe2TkJcEDA-ysdkJMQttEmcOBZCqJqYCohdYFJvlu3EWibmTk172GUH_nLecxyLsgkNcWsaP8exX55_z37vZ0Jeg9sDQKBmicnTLGFFNU2EzXiiNLhiOrOp1Zg7_PW4nJ-wz4tisUMOh1wYDKsMtr-36d5ah38moTcnF207-QbghGPluCEDuH-xS_YymO2rEdmbffoyP44GGRBz2WdNc9-aO9DEGOblaSOR8MgfCoSxXrkn9ES2hZtnqutI9M-Ayt9mqKP75F6AlnTWt_4B2WncQ7I_c-BWn1_SN9QHe_pV9H3ys2ct7ujSUtOswDGOMak07NlQ5WqqzsGhb2uqm7Wi2qc80KWjIegIfrWOdht95uvCNV28AofWr5DTWGUMUqKYldmucEnyETk5-vj9cJ6E4xgSA6BpnWS14NbkAhxqA7DO5AamfkBXxvCapcxazo3mtYEhKHlZqBxcGYF4o4bSasryx2Tklq55Sqi2UysqayzjiH9KoYTKTdooxWvRcD4m74aulyZwleORGT_kEJR2JrcHTuLASYzRy8oxKaL0Rc_ZcUu598MoyyEvFSyphMnllvL8JvmmC2ahk6nsMjmV11R3TD5EyS3t_4dnvxrUUoKBwF0f5ZrlBp7JWM6QuE78pUyRlkiNKKDnn_SqHHsOOfKyqkrh7baUPBZAgvLtO6499UTlAG4FWIJn__12z8lduGL90tcLMlqvNs1LAINrfUB2316lB-GT_wWHw2Z-
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fb9MwELZGJwEvaDB-FAYYCfEWtUmcOBZCUzUxdWzrC5vUN8txbC0Tc6emfeCVv5w7x4lWNqEh3prG5zj25fydffeZkI_g9gAQqFik0ziJWFaMI2ETHqkSXLEysbEtMXf4dJZPz9m3eTbfIgddLgyGVQbb39p0b63DP6PQm6Pruh59B3DCsXLckAHcP39Athkeaj0g25Oj4-msN8iAmPM2a5r71jyEJvZhXp42EgmP_KFAGOuVekJPZFu4e6a6jUT_DKi8MUMd7pAnAVrSSdv6p2TLuGdkd-LArb76ST9RH-zpV9F3ya-WtbihC0u1WYJj3Mek0rBnQ5WrqLoCh76uaGlWipY-5YEuHA1BR_CrdrRZl5e-LlzTxStwaP0KOe2r7IOUKGZl1ktcknxOzg-_nh1Mo3AcQ6QBNK2ipBLc6lSAQ60B1ulUw9QP6EprXkG3W8u5LnmlRVLkPM9UCq6MQLxRQWk1ZukLMnALZ14RWtqxFYXVlnHEP7lQQqU6NkrxShjOh-Rz1_VSB65yPDLjh-yC0i7l5sBJHDiJMXpJPiRZL33dcnbcU-5LN8qyy0sFSyphcrmnPL9L3jTBLDQylk0ix_KW6g7Jfi-5of3_8OwPnVpKMBC466OcWazhmYylDInrxF_KZHGO1IgCev5lq8p9zyFHXlIUMbzdhpL3BZCgfPOOqy88UTmAWwGW4PV_v9178mh6dnoiT45mx2_IY7jD2mWwPTJYLdfmLQDDVfkufPi_Ae_zaGQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+cerebrovascular+disease+and+amyloid+beta+burden+on+cognition+in+subjects+with+subcortical+vascular+cognitive+impairment&rft.jtitle=Neurobiology+of+aging&rft.au=Park%2C+Jae-Hyun&rft.au=Seo%2C+Sang+Won&rft.au=Kim%2C+Changsoo&rft.au=Kim%2C+Sook+Hui&rft.date=2014-01-01&rft.pub=Elsevier+Inc&rft.issn=0197-4580&rft.eissn=1558-1497&rft.volume=35&rft.issue=1&rft.spage=254&rft.epage=260&rft_id=info:doi/10.1016%2Fj.neurobiolaging.2013.06.026&rft.externalDocID=S019745801300287X
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01974580%2FS0197458013X00107%2Fcov150h.gif